In a purely political move, President Obama appoints former VP Joe Biden Chief of Staff Ron Klain to the post of Ebola "czar." No one knows for sure what the lawyer will do in the post since he knows next to nothing about Ebola, the scientific basis for the spread of highly contagious diseases and infection control protocols and procedures. He probably looks good on television, though.
Nano cap (NYSEMKT:IBIO) is up 52% premaket on robust volume in apparent response to its press release about the applicability of its iBioLaunch technology to the development of antibodies that target Ebola. Over zealous traders appear to be ignoring the long-term nature of the applicability.
As previously reported,the company licensed iBioLaunch to would-be ZMapp manufacturer Caliber Biotherapeutics.
Versar (VSR +15%) shares soar after the project management company says it was awarded a $98M firm fixed price design/bid/build task order for the repair of a runway at Dover Air Force Base in Delaware.
VSR says the task order was awarded under its S/R&M acquisition task order contract IDIQ with the Air Force Civil Engineer Center, held with its joint venture partner, Johnson Controls (NYSE:JCI).
Versar Inc together with its subsidiaries provides solutions to government and commercial clients relating construction management, environmental services, munitions response, telecommunications, and energy in the United States.